Reduced b lymphoid kinase (BLK) expression enhances proinflammatory cytokine production and induces nephrosis in C57BL/6-lpr/lpr mice

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Samuelson, Elizabeth M ^a   Laird, Renee M ^a   Papillion, Amber M ^a   Tatum, Arthur H ^b   Princiotta, Michael F ^a   Hayes, Sandra M ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; B LYMPHOID KINASE; FC RECEPTOR; IMMUNOGLOBULIN; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ALPHA BETA T LYMPHOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; B LYMPHOCYTE; BLK GENE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; GAMMA DELTA T LYMPHOCYTE; GENE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; IMMUNOLOGICAL TOLERANCE; LISTERIOSIS; LYMPHOCYTE PROLIFERATION; MOUSE; NATURAL KILLER T CELL; NEPHROSIS; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEINURIA; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMIC LUPUS ERYTHEMATOSUS; TH17 CELL;

ANIMALS; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; CELL COUNT; CYTOKINES; DENDRITIC CELLS; IMMUNE TOLERANCE; INDUCIBLE T-CELL CO-STIMULATOR LIGAND; INDUCIBLE T-CELL CO-STIMULATOR PROTEIN; INFLAMMATION MEDIATORS; KIDNEY; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, INBRED MRL LPR; MICE, TRANSGENIC; NEPHROSIS; PHENOTYPE; PROTEIN BINDING; PROTEINURIA; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SRC-FAMILY KINASES; T-LYMPHOCYTES;

EID: 84898623237     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092054     Document Type: Article

References (102)

1. Fairhurst AM, Wandstrat AE, Wakeland EK (2006) Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease. Adv Immunol 92: 1-69 (Pubitemid 44828118)
2. Krishnan S, Chowdhury B, Tsokos GC (2006) Autoimmunity in systemic lupus erythematosus: Integrating genes and biology. Sem Immunol 18: 230-243 (Pubitemid 43903286)
3. Morel L (2010) Genetics of SLE: evidence from mouse models. Nat Rev Rheumatol 6: 348-357
4. Harley JB, Alarcon-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP,et al.. (2008) Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 40: 204-210 (Pubitemid 351171405)
5. Hom G, Graham RR, Modrek B, Taylor KE, Ortmann W,et al.. (2008) Association of systemic lupus erythematosus with C8orf13-BLK and ITGAMITGAX. N Engl J Med 358: 900-909 (Pubitemid 351397089)
6. Han JW, Zheng HF, Cui Y, Sun LD, Ye DQ,et al.. (2009) Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat. Genet41: 1234-1237
7. Suarez-Gestal M, Calaza M, Endreffy E, Pullmann R, Ordi-Ros J,et al.. (2009) Replication of recently identified systemic lupus erythematosus genetic associations: a case-control study. Arthritis Res Ther 11: R69
8. Sanchez E, Comeau ME, Freedman BI, Kelly JA, Kaufman KM, Langefeld CD,et al.. (2011) Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study. Arthritis Rheum 63: 3493-3501
9. Koga M, Kawasaki A, Ito I, Furuya T, Ohashi J,et al.. (2011) Cumulative association of eight susceptibility genes with systemic lupus erythematosus in a Japanese female population. J Hum Genet 56: 503-507
10. Järvinen TM, Hellquist A, Zucchelli M, Koskenmies S, Panelius J,et al.. (2012) Replication of GWAS-identified systemic lupus erythematosus susceptibility genes affirms B-cell receptor pathway signalling and strengthens the role of IRF5 in disease susceptibility in a Northern European population. Rheumatology 51: 87-92
11. Zhang Z, Zhu KJ, Zu Q, Zhang XJ, Sun LD,et al.. (2010) The association of the BLK gene with SLE was replicated in Chinese Han. Arch Dermatol Res 302: 619-624
12. Delgado-Vega AM, Dozmorov MG, Quiro s MB, Wu YY, Martnez-Garca B,et al.. (2012) Fine mapping and conditional analysis identify a new mutation in the autoimmune susceptibility gene BLK that leads to reduced half-life of the Blk protein. Ann Rheum Dis 71: 1219-1226
13. Simpfendorfer KR, Olsson LM, Manjarrez Orduno N, Khalili H, Simeone AM,et al.. (2012) The autoimmunity-Associated BLK haplotype exhibits cisregulatory effects on mRNA and protein expression that are prominently observed in B cells early in development. Hum Mol Genet 21: 3918-3925
14. Dymecki SM, Niederhuber JE, Desiderio SV (1990) Specific expression of a tyrosine kinase gene, blk, in B lymphoid cells. Science 247: 332-336
15. Texido G, Su IH, Mecklenbräuker I, Saijo K, Malek SN,et al.. (2000) The Bcell- specific Src-family kinase Blk is dispensable for B-cell development and activation. Mol Cell Biol 20: 1227-1233 (Pubitemid 30069243)
16. Saijo K, Schmedt C, Su IH, Karasuyama H, Lowell CA,et al.. (2003) Essential role of Src-family protein tyrosine kinases in NF-kB activation during B cell development. Nat Immunol 4: 274-279 (Pubitemid 36322138)
17. Samuelson EM, Laird RM, Maue AC, Rochford R, Hayes SM (2012) Blkhaploinsufficiency impairs the development, but enhances the functional responses, of MZ B cells. Immunol Cell Biol 90: 620-629
18. Lopes-Cavalho T, Kearney JF (2005) Marginal zone B cell physiology and disease. Curr Dir Autoimmun 8: 91-123
19. Martin F, Chan AC (2006) B cell immunobiology in disease: evolving concepts from the clinic. Ann Rev Immunol 24: 467-496
20. Islam KB, Rabbani H, Larsson C, Sanders R, Smith CIE (1995) Molecular cloning, characterization, and chromosomal localization of human lymphoid tyrosine kinase related to murine Blk. J Immunol 154: 1265-1272
21. Cao W, Zhang L, Rosen DR, Bover L, Watanabe G,et al.. (2007) BDCA2/FceR1c complex signals through a novel BCR-like pathway in human plasmacytoid dendritic cells. PLoS Biol 5: e248
22. Borowiec M, Liew CW, Thompson R, Boonyasrisawat W, Hu J,et al.. (2009) Mutations at the BLK locus linked to maturity onset diabetes of the young and b-cell dysfunction. Proc Natl Acad Sci USA 106: 14460-14465
23. Laird RM, Laky K, Hayes SM (2010) Unexpected role for the B cell-specific Src family kinase B lymphoid kinase in the development of IL-17-producing cd T cells. J Immunol 185: 6518-6527
24. Adachi M, Watanabe-Fukunaga R, Nagata S (1993) Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc Natl Acad Sci USA 90: 1756-1760 (Pubitemid 23069935)
25. Izui S, Kelley VE, Masuda K, Yoshida H, Roths JB,et al.. (1984)Induction of various autoantibodies by mutant gene lpr in several strains of mice. J Immunol 133: 227-233 (Pubitemid 14077907)
26. Li H, Jiang Y, Prak EL, Radic M, Weigert M (2001) Editors and editing of anti- DNA receptors. Immunity.15947957 27
27. Laird RM, Wolf BJ, Princiotta MF, Hayes SM (2013) cd T cells acquire effector fates in the thymus and differentiate into cytokine-producing effectors in a listeria model of infection independently of CD28 stimulation. PLoS One 8: e63178
28. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A,et al.. (2006) The orphan nuclear receptor RORct directs the differentiation program of proinflammatory IL-17 + T helper cells. Cell 126: 1121-1133 (Pubitemid 44380299)
29. Calvani N, Tucci M, Richards HB, Tartaglia P, Silvestris F (2005) Th1 cytokines in the pathogenesis of lupus nephritis: the role of IL-18. Autoimmun Rev 4: 542-548 (Pubitemid 41415767)
30. Craft JE. (2012) Follicular helper T cells in immunity and systemic autoimmunity. Nat Rev Rheumat 8: 337-347
31. Jacob N, Stohl W (2010) Autoantibody-dependent and autoantibodyindependent roles for B cells in systemic lupus erythematosus: past, present, and future. Autoimmunity 43: 84-97
32. Gillet M, Cao W, Liu YJ (2008) Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol. 8: 594-606
33. Korn T, Petermann F (2012) Development and function of interleukin 17- producing cd T cells. Ann NY Acad Sci 1247: 34-45
34. D9Acquisto F, Crompton T (2011) CD3 + CD42CD82 T cells: saviours or villains of the immune response. Biochem Pharmacol 82: 333-340
35. Kyttaris VC, Zhang Z, Kuchroo VK, Oukka M, Tsokos GC (2010) Cutting Edge: IL-23 receptor deficiency prevents the development of lupus nephritis in C57BL/6-lpr/lpr mice. J Immunol 184: 4605-4609
36. Kraft SW, Schwartz MM, Korbet SM, Lewis EJ (2005). Glomerular podocytopathy in patients with systemic lupus erythematosus. J Am Soc Nephrol 16: 175-179 (Pubitemid 43073170)
37. Seshan SV, Jennette JC (2009) Renal disease in systemic lupus erythematosus with emphasis on classification of lupus glomerulonephritis: advances and implications. Arch Pathol Lab Med 133: 233-248
38. Gutierrez S, Petiti JP, De Paul AL, Torres AI, Mukdsi JH (2012) Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis Nefrologia 32: 245-246
39. Brunskill EW, Georgas K, Rumbaue B, Little MH, Potter SS (2011) Defining the molecular character of the developing and adult kidney podocyte. PloS One 6(9): e24640
40. Tai G, Hohenstein P, Davies JA (2013) FAK-Src signaling is important to renal collecting duct morphogenesis: discovery using a hierarchical screening technique. Biol. Open 2: 416-423
41. Navarro JF, Mora C, Rivero A, Gallego E, Chahin J,et al.. (1999) Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: effects of pentoxifylline administration. Am J Kidney Dis 33: 458-463 (Pubitemid 29107022)
42. Segal R, Dayan M, Zinger H, Mozes E (2001) Suppression of experimental systemic lupus erythematosus (SLE) in mice via TNF inhibition by an anti- TNFa monoclonal antibody and by pentoxiphylline. Lupus 10: 23-31 (Pubitemid 32416685)
43. Chan OT, Madaio MP, Schlomchik MJ (1999) The central and multiple roles of B cells in lupus pathogenesis. Immunol Rev 169: 107-121 (Pubitemid 29338727)
44. Lund FE (2008) Cytokine-producing B lymphocytes - key regulators of immunity. Curr Opin Immunol 20: 332-338
45. Barr TA, Shen P, Brown S, Lampropoulou V, Roch T,et al.. (2012) B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6- producing B cells. J Exp Med 209: 1001-1010
46. Watanabe M, Takagi Y, Kotani M, Hara Y, Inamine A,et al.. (2008) Downregulation of ICOS ligand by interaction with ICOS functions as a regulatory mechanism for immune responses. J Immunol 180: 5222-5234
47. Hu H, Wu X, Jin W, Chang M, Cheng X,et al.(2011) Noncanonical NF-kB regulates inducible costimulatory (ICOS) ligand expression and T follicular heler cell development. Proc Natl Acad Sci USA 108: 12827-12832
48. Iwai H, Abe M, Hirose S, Tsushima F., Tezuka K,et al.. (2003) Involvement of inducible costimulator-B7 homologous protein costimulatory pathway in murine lupus nephritis. J Immunol 171: 2848-2854 (Pubitemid 37093504)
49. Hutloff A, Büchner K, Reiter K, Baelde HJ, Odendahl M,et al.. (2004) Involvement of inducible costimulatory in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosus. Arthritis Rheum 50: 3211-3220 (Pubitemid 39371998)
50. Hutloff A, Dittrich AM, Beier KC, Eljaschewitsch B, Kraft R,et al.. (1999) ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 397: 263-266
51. Wassink L, Vieira PL, Smits HH, Kingsbury GA, Coyle AJ,et al.. (2004) ICOS expression by activated human Th cells is enhanced by IL-12 and IL-23: increased ICOS expression enhances the effector function of both Th1 and Th2 cells. J Immunol 173: 1779-1786 (Pubitemid 38971610)
52. Quiroga MF, Pasquinelli V, Martnez GJ, Jurado JO, Zorilla LC,et al.. (2006) Inducible costimulator: a modulator of IFN-c production in human tuberculosis. J Immunol 176: 5965-5974
53. Bauquet AT, Jin H, Paterson AM, Mitsdoerffer M, Ho IC,et al.. (2009) The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells. Nat Immunol 10: 167-175
54. Choi YS, Kageyama R, Eto D, Escobar TC, Johnston RJ,et al.. (2011) ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6. Immunity 34: 932-946
55. Hamada S, Umemura M, Shiono T, Tanaka K, Yahagi A,et al.. (2008) IL-17A produced by cd T cells plays a critical role in innate immunity against Listeria monocytogenes infection in the liver. J Immunol 181: 3456-3463
56. Pau E, Cheung YH, Loh C, Lajoie G, Wither JE (2012) TLR tolerance reduces IFN-A production despite plasmacytoid dendritic cell expansion and antinuclear antibodies in NZB bicongenic mice. PLoS One 7: e36761
57. Palucka AK, Blanck JP, Bennet L, Pascual V, Banchereau J (2005) Crossregulation of TNF and IFN-A in autoimmune diseases. Proc Natl Acad Sci USA 102: 3372-3377 (Pubitemid 40328052)
58. Pisitkun P, Ha HL, Wang H, Claudio E, Tivy CC,et al.. (2012) Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis. Immunity 37: 1104-1115
59. Li H, Chen J, Huang A, Stinson J, Heldens S,et al.. (2000) Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. Proc Natl Acad Sci USA 97: 773-778 (Pubitemid 30070385)
60. Ramirez-Carrozzi V, Sambandam A, Luis E, Lin Z, Jeet S,et al.. (2011) IL-17C regulates the innate immune function of epithelial cells in an autocrine manner. Nat Immunol 12: 1159-1166
61. Riol-Blanco L, Lazarevic V, Awasthi A, Mitsdoerffer M, Wilson BS,et al. 2010 IL-23 receptor regulates unconventional IL-17-producing T cells that control bacterial infections. J Immunol 184. 1710-1720. 2010
62. Rai E, Wakeland EK (2011) Genetic predisposition to autoimmunity - what have we learned Semin Immunol 23: 67-83
63. Morel L, Croker BP, Blenman KR, Mohan C, Huang G,et al.. (2000) Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc Natl Acad Sci USA 97: 6670-6675 (Pubitemid 30412772)
64. Yamamoto M, Yoshizaki K, Kishimoto T, Ito H (2000) IL-6 is required for the development of Th1 cell-mediated murine colitis. J Immunol 164: 4878-4882 (Pubitemid 30238092)
65. Dienz O, Eaton SM, Bond JP, Neveu W, Moquin D,et al.. (2009) The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4 + T cells. J Exp Med 206: 69-78
66. Petermann F, Rothhammer V, Claussen MC, Haas JD, Blanco LR,et al.. (2010). cd T cell enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism. Immunity 33: 351-363
67. Jiang C, Foley J, Clayton N, Kissling G, Jokinen M,et al.. (2007) Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice. J Immunol 178: 7422-7431 (Pubitemid 46847470)
68. Sille FCM, Thomas R, Smith MT, Conde L, Skibola CF (2012) Post-GWAS functional characterization of susceptibility variants for chronic lymphocytic leukemia. PLoS One7: e29632
69. Hsu HC, Yang PA, Wang J, Wu Q, Myers R,et al.. (2008) Interleukin 17- producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 9: 166-175
70. Blaho VA, Buczyniski MW, Dennis EA, Brown CR (2009) Cyclooxygenase-1 orchestrates germinal center formation and antibody class-switch via regulation of IL-17. J Immunol 183: 5644-5653
71. Mitsdoerffer M, Lee Y, Jä ger A, Kim HJ, Korn T,et al.. (2010) Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc Natl Acad Sci USA 107: 14292-14297
72. Wakeland EK, Wandstrat AE, Liu K, Morel L (1999) Genetic dissection of systemic lupus erythematosus. Curr Opin Immunol 11: 701-707
73. Wakeland EK, Liu K, Graham RR, Behrens TW (2001) Delineating the genetic basis of systemic lupus erythematosus. Immunity 15: 397-408 (Pubitemid 32907387)
74. Gourrh P, Agarwal SK, Martin E, Divecha D, Rueda B,et al.. (2010) Association of the C8orf13-BLK region with systemic sclerosis in North- American and European populations. J Autoimmun 34: 155-162
75. Gregersen PK, Amos CI, Lee AT, Lu Y, Remmers EF,et al.. (2009) REL, encoding a member of the NF- kB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis. Nat Genet 41: 820-823
76. Orozco G, Eyre S, Hinks A, Bowes J, Morgan AW,et al.. (2010) Study of the common genetic background for rheumatoid arthrititis and systemic lupus erythematosus. Ann Rheum Dis 70: 463-468
77. Nordmark G, Kristjansdottir G, Theander E, Appel A, Eriksson P,et al.. (2011) Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjogren's syndrome. Genes Immun 12: 100-109
78. Onouchi Y, Ozaki K, Burns JC, Shimizu C, Terai M,et al.. (2012) A genomewide association study identifies three new risk loci for Kawasaki disease. Nat Genet 44: 517-521
79. Lee YC, Kuo HC, Chang JS, Chang LY, Huang LM,et al.. (2012) Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis. Nat Genet 44: 522-525
80. Peng SL, Moslehi J, Craft J (1997) Roles of interferon-c and intereukin-4 in murine lupus. J Clin Invest 99: 1936-1946 (Pubitemid 27175941)
81. Ohshima S, Saeki Y, Mima T, Sasai M, Nishioka K,et al.. (1998) Interleukin 6 plays a key role in the development of antigen-induced arthritis. Proc Natl Acad Sci USA 95: 8222-8226 (Pubitemid 28326094)
82. Young DA, Hegen M, Ma HL, Whitters MJ, Albert LM,et al.. (2007) Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis. Arthritis Rheum 56: 1152-1163 (Pubitemid 46608640)
83. Koca SS, Isik A, Ozercan IH, Usundag B, Evren B,et al.. (2008) Effectiveness of etanercept in bleomycin-induced experimental scleroderma. Rheumatol 47: 172-175 (Pubitemid 351168226)
84. Bubier JA, Sproule TJ, Foreman O, Spolski R, Shaffer DJ,et al.. (2009) A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice. Proc Natl Acad Sci USA 106:1518-1523
85. Zhang Z, Kyttaris VC, Tsokos GC (2010) The role of IL-23/IL-17 axis in lupus nephritis. J Immunol 183: 3160-3169
86. Cash H, Relle M, Menke J, Brochhausen C, Jones SA,et al.. (2010) Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: The IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus. J Rheumatol 37: 60-70
87. Rankin AL, Guay H, Herber D, Bertino SA, Duzanski TA,et al.. (2012) IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Faslpr/lpr/J mice. J Immunol 188: 1656-1667
88. Simons DM, Oh S, Kropf E, Aitken M, Garcia V,et al.. (2013) Autoreactive Th1 cells activate monocytes to support regional Th17 responses in inflammatory arthritis. J Immunol 190: 3134-3141
89. Ohl K, Tenbrock K (2011) Inflammatory cytokines in systemic lupus erythematosus. J Biomed Biotech doi:10.1155/2011/432595
90. Fina D, Fantini MC, Pallone F, Monteleone G (2006) Role of interleukin-21 in inflammation and allergy. Inflam Allergy Drug Targ 6: 63-68 (Pubitemid 46488300)
91. Ma CY, Jiao YL, Zhang J, Yang QR, Zhang ZF,et al.. (2012) Elevated plasma levels of HMGB1 are associated with disease activity and combined alterations with IFN-A and TNF-A in systemic lupus erythematosus. Rheumatol Int 32: 395-402
92. Sato SM. Hasegawa M, Takehara K (2001) Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis. J Dermatol Sci 27: 140-146 (Pubitemid 32781022)
93. Gourh P, Arnett FC, Assassi S, Tan FK, Huang M,et al.. 2009. Plasma cytokine profiles in systemic sclerosis: association with autoantibody subsets and clinical manifestations. Arthritis Res Ther 11: R147
94. Espersen GT, Vestergaard M, Ernst E, Grunnet N (1991) Tumor necrosis factor alpha and interleukin-2 in plasma from rheumatoid arthritis patients in relation to disease activity. Clin Rheumatol 10: 374-376
95. Metsä rinne KP, Nordström DC, Konttinen YT, Teppo AM, Fyhrquist FY (1992) Plasma interleukin-6 and renin substrate in reactive arthritis, rheumatoid arthritis, and systemic lupus erythematosus. Rheumatol Int 12: 93-96
96. Brennan F, Beech J (2007) Update on cytokines in rheumatoid arthritis. Curr Opin Rheum 19: 296-301 (Pubitemid 46597470)
97. Katsifis GE, Rekka S, Moutsopoulos NM, Pillemer S, Wahl SM (2009) Systemic and local interleukin-17 and linked cytokines associated with Sjögren's syndrome immunopathogenesis. Am J Pathol 175: 1167-1177
98. Kang KY, Kim HO, Kwok SK, Ju JH, Park KS,et al.. (2011) Impact of interleukin-21 in the pathogenesis of primary Sjögren's syndrome: increased serum levels or interleukin-21 and its expression in the labial salivary glands. Arth Res Ther 13: R179
99. Cay HF, Sezer I, Dogan S, Felek R, Aslan M (2012) Polymorphism in the TNF-A gene promoter at position -1031 is associated with increased circulating levels of TNF-A, myeloperoxidase and nitrotyrosine in primary Sjögren's syndrome. Clin Exp Rheumatol 30: 843-849
100. Yoshioka T, Matsutani T, Iwagami S, Toyosaki-Maeda T, Yutsudo T,et al.. (1999) Polyclonal expansion of TCRBV2- and TCRBV6-bearing T cells in patients with Kawaski disease. Immunol96: 465-472 (Pubitemid 29118336)
101. Jia S, Li C, Wang G, Yang J, Zu Y (2010) The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki disease. Clin Exp Med 162: 131-137
102. Bae YJ, Kim MH, Lee HY, Uh Y, Namgoong MK,et al.. (2012) Elevated serum levels of IL-21 in Kawasaki Disease. Allergy Asthma Immunol Res e125